Geschäftsentwicklung Bericht der Konzernleitung zur Geschäftsentwicklung (englischer Orginaltext)
Partnerships have always been an important element in Norgine's success and will continue to play a pivotal role in the Company's future. We plan to develop our business both by licensing or acquiring products to market throughout Europe and certain other territories, and by building partnerships for products developed within Norgine in territories where the company does not have its own sales and marketing organisation. In particular Norgine will seek partners for its products in the USA and Japan. To any prospective partner Norgine offers: - An established and proven Sales and Marketing capability throughout Europe and in a number of other key territories
- A management team and corporate culture committed to partnering
- A proven product development and regulatory capability
- A flexible and creative approach to collaborations
- The ability to respond rapidly to opportunities
in-licensing We are seeking products to sell through our established sales and marketing infrastructure. The main therapy targets are: - Gastroenterology – IBD;
- proctologyPain Management – cancer pain; post-operative pain; neuropathic pain
out-licensing Norgine's main priority is to find partners in the USA and Japan for products developed in-house contact To discuss business development and licensing opportunities with Norgine, contact: businessdevelopment@norgine.com
|
